Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US federal appeals court hears arguments in Myriad gene patent case

This article was originally published in SRA

Executive Summary

In a case involving the patentability of isolated DNA, lawyers arguing before the US Court of Appeals for the Federal Circuit on 4 April used hypothetical situations and analogies, for the most part, instead of relying on historical case law on which to base their arguments, with both sides referencing extractions involving everything from baseball bats from trees, to kidneys from the body, to minerals from rocks to get their points across1.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS116103

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel